Sort
46,585 grants matching “heart failure”
Tafazzin and metabolic reprogramming during cardiomyopathy
$564,058Simon J Conway · Indiana University Indianapolis · R01 · FY2023 · HL
Tafazzin and metabolic reprogramming during cardiomyopathy
$564,058Simon J Conway · Indiana University Indianapolis · R01 · FY2022 · HL
Shock, trauma and gut origin of sepsis
$563,979Edwin A Deitch · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · GM
Reducing cardiac toxicity with deep learning and MRI-guided radiation therapy
$563,967Carri Kaye Glide-Hurst · University Of Wisconsin-Madison · R01 · FY2024 · HL
Cardiac Amyloidosis in Aging African Americans
$563,946Scripps Research Institute · R01 · FY2001 · AG
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories, and prognostic significance
$563,941Vasan S. Ramachandran · University Of Texas Hlth Science Center · R01 · FY2022 · HL
Biological and Physiological Mechanisms of Symptom Clusters in Heart Failure (BIOMES-HF)
$563,921Quin Eleanor Denfeld · Oregon Health & Science University · R01 · FY2022 · NR
Role of the unfolded protein response in pathological cardiac remodeling
$563,886Zhao Wang · Beckman Research Institute/City Of Hope · R01 · FY2024 · HL
iPS cells-derived progenitor cells for angiomyogenesis
$563,834Yigang Wang · University Of Cincinnati · R01 · FY2011 · HL
Mouse Models for Ion Homeostasis Defects in Heart
$563,818Gary E Shull · University Of Cincinnati · R01 · FY2010 · HL
Early Identification of Childhood Cancer Survivors at High Risk for Late Onset Cardiomyopathy: An Artificial Intelligence Approach utilizing Electrocardiography
$563,803Oguz Akbilgic · Wake Forest University Health Sciences · R01 · FY2022 · CA
Peripheral Mechanisms of Cardiopulmonary Control during Exercise
$563,801Thomas Patrick Olson · Mayo Clinic Rochester · R01 · FY2018 · HL
Real time risk prognostication via scalable hazard trees and forests
$563,767Hemant Ishwaran · University Of Miami School Of Medicine · R01 · FY2024 · HL
PAR1 as a Therapeutic Target in Doxorubicin-induced Cardiotoxicity
$563,715Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
PAR1 as a Therapeutic Target in Doxorubicin-induced Cardiotoxicity
$563,715Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
PAR1 as a Therapeutic Target in Doxorubicin-induced Cardiotoxicity
$563,715Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
PARs and S1P receptors in endothelial biology
$563,706Shaun R. Coughlin · University Of California, San Francisco · R01 · FY2010 · HL
Associations of smoke from wildfires and prescribed burns with cardiorespiratory health outcomes in Reno, NV
$563,650Matthew J. Strickland · University Of Nevada Reno · R01 · FY2022 · ES
FKBP Interaction with RYR Calcium Channels in Heart
$563,644Donald M Bers · University Of California At Davis · R01 · FY2011 · HL
A Multi-omics evaluation of Carfilzomib-related Cardiotoxicity
$563,632Yan Gong · University Of Florida · R01 · FY2022 · HL
TRPV4-PI3K Axis Mediates Pulmonary and Cardiac Fibrosis
$563,500Mitchell Alan Olman · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · HL
Small Molecule Therapeutic for Heart Failure
$563,500Sathyamangla V Prasad · Cleveland Clinic Lerner Com-Cwru · R61 · FY2024 · HL
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population
$563,496Joanne E Curran · University Of Texas Rio Grande Valley · R01 · FY2021 · DK
CRF and Urocortins and Their Receptors
$563,393Wylie W. Vale · Salk Institute For Biological Studies · P01 · FY2012 · DK
EXercise MRI evaluation of HIV-PAH Longitudinal Determinants(EXHALTED)
$563,391Sanjay Rajagopalan · University Of Maryland Baltimore · R01 · FY2016 · HL